Breaking News

BMS Consolidates Candiac Operations To NJ

Bristol-Myers Squibb Canada plans to consolidate its Clinical Supply Operations (CSO) and related functions located in Candiac into its recently expanded New Brunswick, NJ facility.

The CSO and related functions represent 75% of all Candiac site positions. The company’s decision to close the Candiac facility affects approximately 115 employees. The company is offering opportunities to transfer to New Brunswick, NJ and other BMS sites in the U.S. Others will be offered severance and outplacement assistance.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters